Pramipexole Safely Replaces Ergot Dopamine Agonists with either Rapid or Slow Switching

Author： Takahashi H   Nogawa S   Tachibana H   Kawamura J   Abe T   Ogino Y   Kashihara K   Hamada T   Kowa H    

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.36, Iss.1, 2008-01, pp. : 106-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

. . . and ergot-derived dopamine agonists . . .

By  

Reactions Weekly, Vol. 1, Iss. 1209, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Inhibition of dopamine neuron firing by pramipexole, a dopamine D 3 receptor-preferring agonist: comparison to other dopamine receptor agonists

By Piercey M.F.   Hoffmann W.E.   Smith M.W.   Hyslop D.K.  

European Journal of Pharmacology, Vol. 312, Iss. 1, 1996-09 ,pp. : 35-44

Elsevier

Access to resources Recommend Favorite

The Link Between Non-Ergot-Derived Dopamine Agonists and Heart Failure: How Strong Is It?

By  

The Consultant Pharmacist, Vol. 30, Iss. 3, 2015-03 ,pp. : 136-140

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Pramipexole Responsive Neck Numbness: The Therapeutic Role of Dopamine Agonists in the Spinal Cord Indicating to a Common Spinal Pathophysiology with Restless Leg Syndrome (RLS)?

By  

Current Clinical Pharmacology, Vol. 11, Iss. 3, 2016-09 ,pp. : 221-222

Bentham Science Publishers

Access to resources Recommend Favorite

The behavioural effects of pramipexole, a novel dopamine receptor agonist

By Maj J.   Rogoz Z.   Skuza G.   Kolodziejczyk K.  

European Journal of Pharmacology, Vol. 324, Iss. 1, 1997-04 ,pp. : 31-37

Elsevier

Access to resources Recommend Favorite